![Allan Wehnert](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Allan Wehnert
Geen lopende functies
Health Technology
Profiel
Allan Wehnert is the founder of Orocidin AS, established in 2023, and holds the title of Chief Executive Officer.
Former jobs include VP-R&D Project Strategy & Portfolio Management at H.
Lundbeck A and Senior Vice President-Clinical, R&D Strategy at Initiator Pharma A.
Actieve functies van Allan Wehnert
| Bedrijven | Functie | Begin |
|---|
Eerdere bekende functies van Allan Wehnert
| Bedrijven | Functie | Einde |
|---|---|---|
| INITIATOR PHARMA A/S | Hoofd Techniek/Wetenschap/O&O | - |
| H. LUNDBECK A/S | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
H. Lundbeck A/S
 H. Lundbeck A/S Pharmaceuticals: MajorHealth Technology Engages in the research, development, production and sale of pharmaceuticals for the treatment of brain diseases | Health Technology |
Initiator Pharma A/S
 Initiator Pharma A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs to unmet medical needs within the central & peripheral nervous system | Health Technology |
Kies MarketScreener 
